Cresco Labs (CRLBF) Change in Accured Expenses (2020 - 2026)

Cresco Labs' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$7.6 million for Q1 2026.

• Quarterly Change in Accured Expenses fell 154.76% year-over-year to -$7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.9 million (down 430.3% YoY) and the FY2025 annual result came in at $8.6 million, up 150.94% from the prior year.
• Change in Accured Expenses was -$7.6 million for Q1 2026 at Cresco Labs, down from $10.6 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $20.1 million in Q1 2023 and bottomed at -$20.5 million in Q4 2024.
• A 5-year average of $1.7 million and a median of $934500.0 in 2022 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 38751.28% in 2022, while the deepest fall reached 5712.78% in 2022.
• Cresco Labs' Change in Accured Expenses stood at $15.1 million in 2022, then plunged by 176.34% to -$11.5 million in 2023, then sank by 77.9% to -$20.5 million in 2024, then soared by 151.87% to $10.6 million in 2025, then plunged by 171.8% to -$7.6 million in 2026.
• Business Quant data shows CRLBF's Change in Accured Expenses at -$7.6 million in Q1 2026, $10.6 million in Q4 2025, and -$5.3 million in Q3 2025.